Anna Clark, Editor
Anna is a Senior Editor for the BMC-series and has been the Editor of BMC Psychology since March 2015. Before joining BioMed Central, Anna received her PhD in Neuroscience from King's College London, UK and was a post-doctoral fellow for a number of years. Anna’s interests for ‘all things brainy’ stem from her undergraduate studies at University College London, UK where she developed a keen interest in psychopharmacology, which led to her passion for pain; a PhD and subsequent post-docs (King's College London, UK and Medical University of Vienna, Austria) where she studied neuron-immune cell interactions in chronic pain conditions. Anna is involved in a trial of ‘Results-free peer-review’ which is currently running on BMC Psychology; the trial is aiming to improve the quality of published research by focusing editorial decisions on the scientific merits of the rationale and validity of study design. Anna also writes on the BioMed Central blog network and is an Editor of the BMC Series blog
Keith Laws is Professor of Cognitive Neuropsychology in the School of Life and Medical Sciences at the University of Hertfordshire, UK. He completed a PhD at the Department of Experimental Psychology, University of Cambridge and is the author of over 100 papers and a book entitled 'Category-Specificity: Evidence for Modularity of Mind'. He is a Chartered Psychologist, an Associate Fellow of the British Psychological Society, a Fellow of the Royal Society of Arts, a Fellow of the Institute of Learning and Teaching. He joined to Editorial Board of BMC Psychology as a Section Editor in 2013. He is also currently on the editorial boards of the British Journal of Clinical Psychology, PlosOne and World Journal of Psychiatry.
His research focuses on cognitive functioning in people suffering from neurological and psychiatric disorders including schizophrenia, Alzheimer’s disease, OCD, and body dysmorphic disorder. He has published numerous meta-analyses looking at a wide range of topics including the link between MDMA (ecstasy) drug use and poor memory, the use of ketamine as an antidepressant, sex differences in the cognitive decline associated with Alzheimer’s disease, and whether CBT reduces the symptoms of psychosis. His research has attracted national and international media attention including his work documenting worse cognitive outcomes in women suffering from Alzheimer's disease, better multitasking abilities in women than men, the impact of MDMA (ecstasy) on memory function and the use of Ketamine as an anti-depressant.